- Our Team
- For Patients
- Treatments & Services
- Medical Professionals
Clinical Trial
Clinical Trial Search
Trial Protocol ID USOR 20138_D361BC00001 *STAR*
Trial Description
A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Abiraterone Versus Placebo + Abiraterone as Treatment for Patients with De Novo Metastatic Hormone Sensitive Prostate Cancer(mHSPC) Characterised by PTEN deficiency (CAPItello-281)
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724